105 related articles for article (PubMed ID: 8579748)
21. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
Akerblad P; Sigvardsson M
J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
[TBL] [Abstract][Full Text] [Related]
22. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage.
Chiang MY; Monroe JG
Blood; 1999 Dec; 94(11):3621-32. PubMed ID: 10572073
[TBL] [Abstract][Full Text] [Related]
23. The role of B-cell-specific activator protein in the response of malignant B-1 cells to LPS.
Zhang M; Chong SY; Raveche ES
Exp Cell Res; 2001 Apr; 264(2):233-43. PubMed ID: 11262180
[TBL] [Abstract][Full Text] [Related]
24. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.
Zwollo P; Desiderio S
J Biol Chem; 1994 May; 269(21):15310-7. PubMed ID: 8195169
[TBL] [Abstract][Full Text] [Related]
25. Dependence of BSAP repressor and activator functions on BSAP concentration.
Wallin JJ; Gackstetter ER; Koshland ME
Science; 1998 Mar; 279(5358):1961-4. PubMed ID: 9506950
[TBL] [Abstract][Full Text] [Related]
26. The transcription factor B cell-specific activator protein (BSAP) enhances both IL-4- and CD40-mediated activation of the human epsilon germline promoter.
Thienes CP; De Monte L; Monticelli S; Busslinger M; Gould HJ; Vercelli D
J Immunol; 1997 Jun; 158(12):5874-82. PubMed ID: 9190940
[TBL] [Abstract][Full Text] [Related]
27. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.
Masten SA; Shiverick KT
Biochem Biophys Res Commun; 1995 Jul; 212(1):27-34. PubMed ID: 7541987
[TBL] [Abstract][Full Text] [Related]
28. A nuclear DNA-binding protein expressed during early stages of B cell differentiation interacts with diverse segments within and 3' of the Ig H chain gene cluster.
Liao F; Giannini SL; Birshtein BK
J Immunol; 1992 May; 148(9):2909-17. PubMed ID: 1349323
[TBL] [Abstract][Full Text] [Related]
29. Pax-5 is identical to EBB-1/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes.
Tian J; Okabe T; Miyazaki T; Takeshita S; Kudo A
Eur J Immunol; 1997 Mar; 27(3):750-5. PubMed ID: 9079818
[TBL] [Abstract][Full Text] [Related]
30. [B cell development and Ig gene rearrangement].
Katogi R; Kudo A
Nihon Rinsho; 2005 Apr; 63 Suppl 4():243-7. PubMed ID: 15861663
[No Abstract] [Full Text] [Related]
31. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development.
Wallin JJ; Rinkenberger JL; Rao S; Gackstetter ER; Koshland ME; Zwollo P
J Biol Chem; 1999 May; 274(22):15959-65. PubMed ID: 10336503
[TBL] [Abstract][Full Text] [Related]
32. The growth-regulatory role of B-cell-specific activator protein in NZB malignant B-1 cells.
Chong SY; Zhang M; Lin YC; Coffman F; Garcia Z; Ponzio N; Raveche ES
Cancer Immunol Immunother; 2001 Mar; 50(1):41-50. PubMed ID: 11315509
[TBL] [Abstract][Full Text] [Related]
33. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
Dörfler P; Busslinger M
EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
[TBL] [Abstract][Full Text] [Related]
34. A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes.
Milili M; Gauthier L; Veran J; Mattei MG; Schiff C
Immunology; 2002 Aug; 106(4):447-55. PubMed ID: 12153506
[TBL] [Abstract][Full Text] [Related]
35. Immunology. End game for B cells.
Calame K
Nature; 2001 Jul; 412(6844):289-90. PubMed ID: 11460147
[No Abstract] [Full Text] [Related]
36. Transcription factor regulation of B lineage commitment.
Kee BL; Murre C
Curr Opin Immunol; 2001 Apr; 13(2):180-5. PubMed ID: 11228411
[TBL] [Abstract][Full Text] [Related]
37. Human BSAP and BLIMP1 conform an autoregulatory feedback loop.
Mora-López F; Reales E; Brieva JA; Campos-Caro A
Blood; 2007 Nov; 110(9):3150-7. PubMed ID: 17682124
[TBL] [Abstract][Full Text] [Related]
38. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.
Horcher M; Souabni A; Busslinger M
Immunity; 2001 Jun; 14(6):779-90. PubMed ID: 11420047
[TBL] [Abstract][Full Text] [Related]
39. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells.
Emelyanov AV; Kovac CR; Sepulveda MA; Birshtein BK
J Biol Chem; 2002 Mar; 277(13):11156-64. PubMed ID: 11799127
[TBL] [Abstract][Full Text] [Related]
40. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation.
Barberis A; Widenhorn K; Vitelli L; Busslinger M
Genes Dev; 1990 May; 4(5):849-59. PubMed ID: 2116362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
